Clinical Trials Browser

Withdrawn × Interventional × Alzheimer Disease × Clear all

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT04984330 2022-11-17

STARR

Phase EARLY_PHASE1 Withdrawn

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis

NCT04942184 2022-11-01

STRATEGIES to Improve Memory in Alzheimer's Disease

Phase NA Withdrawn

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT02072252 2017-08-17

TODAY!

Phase 1/2 Withdrawn

Endocrine

Generalized Anxiety Disorder, Alzheimer Disease, Anxiety Disorders, Bisexuality, Depression, Homosexuality, Multiple Endocrine Neoplasia Type 1

NCT00711204 2012-12-10

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

Phase 4 Withdrawn

Lymphoid

Alzheimer Disease, Lymphoma, Follicular